Ionis Pharmaceuticals names new executive vice president, chief global product strategy officer

Allergy Therapeutics reports positive G306 Phase III trial results for Grass MATA MPL

NeoImmuneTech's NT-I7 receives US FDA Orphan Drug Designation

Allergy Therapeutics reports positive interim results for G306 Phase III trial

Amytrx Therapeutics names new directors

Inimmune signs research collaboration with Boston Children's Hospital

KalVista Pharmaceuticals unveils analysis on HAE attacks during long-term prophylaxis at APAAACI 2023

ResVita Bio receives USD250,000 phase one Small Business Innovation Research grant from NIAID

The Access to Advanced Health Institute Receives USD 18m Award to Develop a Temperature Stable, Single-Dose Chikungunya RNA Vaccine Through a Phase 1 Clinical Trial

Phase II Data of Oral Dexpramipexole Published in Eosinophilic Asthma

AllerVie Health Rebrands Southern Allergy & Asthma

Applied BioCode Inks Distribution Agreement with Medline Industries

Vedanta Biosciences Receives Fast Track Designation for VE303

KalVista Pharmaceuticals Presents Data at 13th C1-inhibitor Deficiency & Angioedema Workshop

French Ophthalmology Specialist Horus Pharma Group Launches a Nordic Subsidiary